GA
ACLS icon

Geneva Advisors’s Axcelis ACLS Stock Holding History

Geneva Advisors’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$596K Buy
+28,425
New +$601K 0.01% 482

Other funds holding ACLS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geneva Advisors's ACLS Position: Q2 2017 in Review

Geneva Advisors opened a new position in Axcelis (ACLS) in Q2 2017: 28,425 shares worth $596K. The stake represents 0.01% of the portfolio and ranks #482 among its holdings.

130 funds tracked by Wall St. Rank hold ACLS as of Q2 2017.

  • Geneva Advisors held 28,425 shares of Axcelis worth $596K as of Q2 2017.
  • Axcelis was a new Geneva Advisors position in Q2 2017.
  • Axcelis made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #482 holding.
  • 130 funds tracked by Wall St. Rank held Axcelis as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.